Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-005365
Filing Date
2017-05-10
Accepted
2017-05-10 16:44:55
Documents
66
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q teligentinc10q03312017.htm 10-Q 747079
2 EXHIBIT 31.1 tlgtq12017ex311.htm EX-31.1 10246
3 EXHIBIT 31.2 tlgtq12017ex312.htm EX-31.2 10350
4 EXHIBIT 32.1 tlgtq12017ex321.htm EX-32.1 5580
5 EXHIBIT 32.2 tlgtq12017ex322.htm EX-32.2 5819
  Complete submission text file 0001628280-17-005365.txt   4996296

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tlgt-20170331.xml EX-101.INS 891512
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlgt-20170331.xsd EX-101.SCH 42015
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tlgt-20170331_cal.xml EX-101.CAL 66962
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tlgt-20170331_def.xml EX-101.DEF 267158
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlgt-20170331_lab.xml EX-101.LAB 616069
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlgt-20170331_pre.xml EX-101.PRE 369101
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 6096971441
Teligent, Inc. (Filer) CIK: 0000352998 (see all company filings)

EIN.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-08568 | Film No.: 17831111
SIC: 2834 Pharmaceutical Preparations